Unstable angina pathophysiology describes how reduced blood flow and plaque vulnerability trigger sudden cardiac symptoms at rest. Understanding these mechanisms helps clinicians recognize risk and guide urgent intervention.
Stable mechanisms differ markedly from unstable patterns, highlighting the importance of precise diagnosis and risk stratification.
| Feature | Stable Angina | Unstable Angina | Key Pathophysiological Concept |
|---|---|---|---|
| Symptoms at Rest | Rare, usually with exertion | Common, often at rest or with minimal effort | Plaque rupture and thrombosis |
| ECG Changes | Often normal or transient | Persistent ST depression or T-wave inversion | Ongoing myocardial ischemia |
| Biomarker Rise | Absent | Absent (no infarction) | Intact myocardium despite ischemia |
| Thrombus Stability | Thrombus formed but stable | Thrombus formed, partially obstructive, often unstable | Dynamic obstruction and recurrent ischemia |
| Risk of Progression | Lower short-term risk | High risk of myocardial infarction or death | Vulnerable plaque characteristics |
Pathophysiology of Coronary Plaque Rupture
From Stable Plaque to Acute Obstruction
Unstable angina pathophysiology often begins with a thin-cap fibroatheroma, a lipid-rich plaque with a large necrotic core and a weak, inflamed fibrous cap. Hemodynamic stress, plaque inflammation, and matrix metalloproteinases degrade the cap, leading to fissuring or rupture.
Thrombus Formation and Dynamic Obstruction
When the cap ruptures, highly thrombogenic tissue factor–rich plaque contents contact circulating blood, triggering rapid thrombus formation. This thrombus can partially occlude the coronary lumen, reducing flow unpredictably and causing recurrent episodes of myocardial ischemia even at rest.
Role of Inflammation and Endothelial Dysfunction
Endothelial Activation and Leukocyte Recruitment
Chronic risk factors such as hypertension, diabetes, and smoking promote endothelial dysfunction. Activated endothelium expresses adhesion molecules, recruiting monocytes and T-cells into the intima, amplifying inflammation, and further destabilizing the plaque.
Biomarkers and Clinical Implications
Elevated high-sensitivity C-reactive protein and other inflammatory markers correlate with increased risk of plaque rupture. Recognizing this inflammatory phenotype supports aggressive risk modification, including statins and lifestyle changes, to stabilize lesions.
Clinical Syndromes Driven by Unstable Pathophysiology
From Unstable Angina to Non-ST Elevation Myocardial Infarction
Variable degrees of coronary obstruction produce unstable angina, non-ST elevation myocardial infarction, or ST elevation myocardial infarction. In unstable angina, thrombus formation is typically transient or subocclusive, without complete coronary occlusion or myocardial necrosis.
Dynamic Electrocardiographic and Perfusion Changes
Symptoms and ECG abnormalities fluctuate as thrombi form and partially lyse. Serial ECGs and cardiac biomarkers are essential to distinguish unstable angina from evolving myocardial infarction and guide timely revascularization strategies.
Key Pathophysiology Takeaways and Practical Steps
- Identify thin-cap fibroatheromas as the primary substrate for plaque rupture
- Recognize that dynamic thrombosis causes fluctuating obstruction and symptoms
- Monitor inflammatory biomarkers alongside ECG trends for risk stratification
- Initiate dual antiplatelet therapy and statin treatment promptly to stabilize plaques
- Prepare for early invasive management when ischemia recurs despite medical therapy
FAQ
Reader questions
What specific coronary plaque features define unstable angina pathophysiology?
Unstable angina is driven by thin-cap fibroatheromas with large lipid cores, active inflammation, and a fibrous cap prone to rupture, exposing thrombogenic material without necessarily causing complete vessel occlusion.
How does plaque rupture lead to transient coronary obstruction without myocardial necrosis?
Rupture triggers rapid thrombus formation that transiently reduces coronary flow, causing ischemia and symptoms; because thrombus is often lysed or nonocclusive, cardiac troponin levels remain within normal limits.
Which hemodynamic and inflammatory factors worsen ischemia in unstable angina?
Platelet aggregation, vasoconstriction from autonomic activation, coronary artery spasm, and systemic inflammatory cytokines can further reduce flow and amplify symptoms despite only partial mechanical obstruction.
How does understanding pathophysiology guide urgent treatment decisions in unstable angina?
Recognition of plaque rupture and dynamic obstruction supports early use of antiplatelet agents, anticoagulants, and timely angiography to restore perfusion and prevent progression to myocardial infarction.